Geriatrics RehabilitationNCT07042464
Effect of Modified Poco-Poco Exercise to Aging Biomarkers in Elderly
A study testing Modified poco-poco exercises in people with Geriatrics Rehabilitation, run by Universitas Padjadjaran at 1 site in Indonesia.
Trial summary
Subject with sarcopenia get modified poco-poco exercise program for 12 weeks Read more about this study
- Who is it for?
- Ages 60 years and older
- Conditions the study is for
- Geriatrics Rehabilitation
- What is being tested?
- Modified poco-poco exercises
- Type of treatment
- Surgery or procedure
- Could I receive a placebo?
- No, everyone receives an active treatment
- How many people
- 34 participants
- Where
- 1 siteIndonesia
- Study dates
- 20 Jun 2025to 20 Sep 2025
- Phase
- Interventional
- Are there results?
- None posted in the registry
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 60 years and older
- All sexes
- No healthy volunteers
- Adult, Older adult
Who may be able to join
- Age above 60 years old
- Have sarcopenia (based on AWGSOP 2019 criteria)
Who cannot join
- Hearing impairment/loss hindering participants to receive verbal instructions
- Vision impairment/loss hindering participants to receive instructions
- Musculoskeletal impairment or severe joint diseases (i.e. deformity in Osteoarthritis or Rheumatoid Arthritis)
- Participants have been involved in other exercise program
- Severe cardiovascular disease diagnosed by Cardiologist.
- Participants will be excluded from the research if they skip 3 sessions of the program consecutively or skip 5 sessions cumulatively
Trial locations and contacts
1 site in 1 country.
About this study
Official title: Effect of Modified Poco-Poco Exercise to Global DNA Methylation, Growth Differentiation Factor-15, and Sarcopenia Staging in Elderly
Subject with sarcopenia get modified poco-poco exercise program for 12 weeks
Read the detailed description
34 participants (>60 years) with sarcopenia were modified poco-poco exercises three times weekly for 12 weeks will assessed sarcopenia staging (determined by assessing skeletal muscle index, muscle strength, physical performance) and levels of global DNA methylation and GDF-15.
- Conditions
- Geriatrics Rehabilitation
- Being tested
- Modified poco-poco exercises
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
Modified poco-poco exercisesProcedure or surgery
Participants performed modified poco-poco exercises three times weekly for 12 weeks
| Study group | Role | What they receive |
|---|---|---|
| Modified poco-poco exercises | Experimental | Participants performed modified poco-poco exercises three times weekly for 12 weeks and were assessed, including sarcopenia staging (determined by assessing skeletal muscle index, muscle strength, physical performance) and levels of global DNA methylation and GDF-15 Receives: Procedure: Modified poco-poco exercises |
What is being measured
The primary outcome is the main question the study is designed to answer.
Sarcopenia Staging (Skeletal Muscle Index)
Skeletal muscle index
Measured: 12 weeks
Sarcopenia Staging (Muscle Strength)
Hand Grip Strength, score in kilograms
Measured: 12 weeks
Sarcopenia Staging (Physical Performance)
Short Physical Performance Battery, score in numerical 0-12
Measured: 12 weeks
Levels of Global DNA Methylation
Global DNA methylation levels were analyzed using the ELISA-based kit
Measured: 12 weeks
Levels of Growth Differentiation Factor 15
Growth Differentiation Factor 15 were analyzed the Quantikine ELISA Human GDF-15 Immunoassay
Measured: 12 weeks
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted29 Jun 2025
- Study start20 Jun 2025
- Primary completion20 Sep 2025
- Study completion20 Sep 2025
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Other trials for Geriatrics RehabilitationStudies of the same condition, open and under way.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Interventional
- Phase
- Phase N/A
- Primary purpose
- Treatment
- Allocation
- Not applicable
- Intervention model
- Single group
- Model description
- All research subjects received modified poco-poco exercise program for 12 weeks
- Masking
- None (open label)
- Enrolment
- 34 participants (actual)
Sponsor and investigators
- Lead sponsor
- Universitas Padjadjaran
- Sponsor type
- University, hospital or other
- Responsible party
- Principal investigator, Irma Ruslina Defi, Universitas Padjadjaran
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT07042464
- Sponsor's protocol ID
- IKFR.11_2.06.25
- Status last verified
- Apr 2026
- First submitted
- 11 Jun 2025
- Last updated
- 6 May 2026
- Results posted
- No
- Data monitoring committee
- No
- FDA-regulated drug
- No
- FDA-regulated device
- No
Study at a glance
From the registry record, last updated by the sponsor on 6 May 2026. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- Effect of Modified Poco-Poco Exercise to Global DNA Methylation, Growth Differentiation Factor-15, and Sarcopenia Staging in Elderly
- ClinicalTrials.gov ID
- NCT07042464
- Acronym / sponsor ID
- IKFR.11_2.06.25
- Conditions
- Geriatrics Rehabilitation
- Study type
- Interventional
- Recruitment status
- Completed
- Enrolment
- 34 participants (actual)
- Lead sponsor
- Universitas PadjadjaranUniversity, hospital or other
- Study start
- 20 Jun 2025 (actual)
- Primary completion
- 20 Sep 2025 (actual)
- Study completion
- 20 Sep 2025 (actual)
- First posted
- 29 Jun 2025 (actual)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
Subject with sarcopenia get modified poco-poco exercise program for 12 weeks
Detailed description
34 participants (>60 years) with sarcopenia were modified poco-poco exercises three times weekly for 12 weeks will assessed sarcopenia staging (determined by assessing skeletal muscle index, muscle strength, physical performance) and levels of global DNA methylation and GDF-15.
Study design
- Primary purpose
- Treatment
- Allocation
- Not applicable
- Intervention model
- Single group
- Masking
- None (open label)
- Number of arms
- 1
- Model description
- All research subjects received modified poco-poco exercise program for 12 weeks
| Arm | Type | Receives |
|---|---|---|
| Modified poco-poco exercises | Experimental | Procedure: Modified poco-poco exercisesParticipants performed modified poco-poco exercises three times weekly for 12 weeks and were assessed, including sarcopenia staging (determined by assessing skeletal muscle index, muscle strength, physical performance) and levels of global DNA methylation and GDF-15 |
Who may qualify
- Ages
- 60 years and older
- Sex
- All
- Healthy volunteers
- Not accepted
- Age groups
- Adult, Older adult
Key inclusion criteria (2 listed)
- Age above 60 years old
- Have sarcopenia (based on AWGSOP 2019 criteria)
Key exclusion criteria (6 listed)
- Hearing impairment/loss hindering participants to receive verbal instructions
- Vision impairment/loss hindering participants to receive instructions
- Musculoskeletal impairment or severe joint diseases (i.e. deformity in Osteoarthritis or Rheumatoid Arthritis)
- Participants have been involved in other exercise program
- Severe cardiovascular disease diagnosed by Cardiologist.
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Interventions
| Intervention | Type | Arms |
|---|---|---|
| Modified poco-poco exercisesParticipants performed modified poco-poco exercises three times weekly for 12 weeks | Procedure or surgery | Modified poco-poco exercises |
Primary outcome
Sarcopenia Staging (Skeletal Muscle Index)
Time frame: 12 weeks
Skeletal muscle index
Sarcopenia Staging (Muscle Strength)
Time frame: 12 weeks
Hand Grip Strength, score in kilograms
Sarcopenia Staging (Physical Performance)
Time frame: 12 weeks
Short Physical Performance Battery, score in numerical 0-12
Levels of Global DNA Methylation
Time frame: 12 weeks
Global DNA methylation levels were analyzed using the ELISA-based kit
Levels of Growth Differentiation Factor 15
Time frame: 12 weeks
Growth Differentiation Factor 15 were analyzed the Quantikine ELISA Human GDF-15 Immunoassay
Results and safety
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 6 May 2026.
Related trials for Geriatrics Rehabilitation
Active, not recruiting
Comparative Effects of Balance and Inspiratory Muscle Training in Older Adults
Geriatric, Geriatrics Rehabilitation
Not yet recruiting
Backward Walking Rehabilitation to Prevent Falls in High-risk Adults Aged 75 Years and Older
High Risk of Falling
Not yet recruitingObservational study
State of Knowledge Among Nurses Regarding the Screening for Orthostatic Hypotension in Elderly Individuals in Acute Geriatric Medicine and Medical and Rehabilitation Services
Orthostatic Hypotension
Not yet recruiting
Digitally Assisted Rehabilitation at Home for Older Adults After Hip Surgery (GRIMSEL)
Hip Surgery, Rehabilitation Program
Recruiting
The Influence of Movement Velocity Biofeedback on Muscle Activation and Self Perception in Older Adults With Sarcopenia
Sarcopenia, Sarcopenia in Elderly
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part. This study is not recruiting at the moment.
The record lists no contact. Use the official record to reach the sponsor.
1 site in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
A study testing Modified poco-poco exercises in people with Geriatrics Rehabilitation, run by Universitas Padjadjaran at 1 site in Indonesia.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 2 inclusion and 6 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: finished, as of the sponsor's last update on 6 May 2026. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 1 site in Indonesia. Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
How can a doctor refer a patient or contact the research team?
The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
Sarcopenia Staging (Skeletal Muscle Index) (time frame: 12 weeks). The study lists 5 primary outcomes in all. It is what the study was designed to measure, not a finding.
Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 6 May 2026.